AbbVie and MPP complete a new licensing agreement to ensure access to G/P in 99 low- and middle-income (LMIC) countries and territories
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Tools and information for microelimination of Hepatitis C
AbbVie and MPP complete a new licensing agreement to ensure access to G/P in 99 low- and middle-income (LMIC) countries and territories
Microelimination.org: resources for individuals and organizations interested in hepatitis C microelimination 